Our Research
Exelixis, Positive News from Celestial Study, Cabometyx Label Review Due February 15, 2018
Company Overview Exelixis, Inc. (NASDAQ: EXEL) is a pharmaceutical company that develops and commercializes medicines to improve care and outcomes for...
Rigel Pharmaceuticals, Fostamatinib Clinical Trials Update, and Recent Capital Raise
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is a biotechnology company dedicated to discovering, developing, and providing novel small molecule drugs t...
Aptevo Therapeutics, ADAPTIR Platform and Recent Drug Asset Sale
Aptevo Therapeutics Inc. (NASDAQ: APVO) is a clinical-stage biotechnology company focused on novel oncology and hematology therapeutics to improve pat...